血清胆固醇外流能力与ST段抬高型心肌梗死患者死亡率的关联
在1609例急性心肌梗死连续住院患者中测量血清胆固醇外流能力等指标,中位随访1.9年评估6年全因死亡率。完全校正模型显示,血清胆固醇外流能力每增加1个标准差,死亡风险调整后风险比为0.79(95%CI 0.66-0.95,P=0.0132);外流能力较高者6年死亡率显著低于较低者(调整后HR 0.54,95%CI 0.32-0.89,P=0.0165)。结论认为该指标独立于HDL胆固醇水平与全因死亡率呈负相关。
要点
- 外流能力较高者6年死亡率显著低于较低者(调整后HR 0.54)。
- 该预后关联独立于HDL胆固醇水平及其他传统危险因素。
核心结论
- 血清胆固醇外流能力作为逆向胆固醇转运途径的整合性标志物,与心肌梗死患者全因死亡率独立负相关,且不依赖HDL胆固醇水平。
研究设计与样本
- 在1609例连续因急性心肌梗死住院的患者中测量血清胆固醇外流能力、CETP活性、总胆固醇、LDL胆固醇、HDL胆固醇和甘油三酯水平。
- 主要终点为6年全因死亡率,中位随访1.9年(四分位距1.5-4.2年),并按血清胆固醇外流能力四分位进行分析。
主要发现
- 在包含年龄、性别、传统心血管危险因素(含脂质水平)及心梗预后因素的完全校正模型中,血清胆固醇外流能力每增加1个标准差,死亡调整后风险比为0.79(95%CI 0.66-0.95,P=0.0132)。
- 血清胆固醇外流能力较高者6年死亡率显著低于较低者,调整后风险比为0.54(95%CI 0.32-0.89,P=0.0165)。
临床怎么用
- 血清胆固醇外流能力可作为心梗患者预后评估的潜在生物标志物,独立于HDL胆固醇水平提供额外风险分层信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serum cholesterol efflux capacity, a biomarker that integrates contributors and modulators of the initial step of the reverse cholesterol transport, has been associated with atherosclerosis independently of high-density lipoprotein (HDL) cholesterol level. OBJECTIVES: The authors evaluated the prognostic impact of serum cholesterol efflux capacity on mortality in a large cohort of patients hospitalized for an acute myocardial infarction (MI). METHODS: Serum cholesterol efflux capacity, cholesteryl ester transfer protein (CETP) activity, total cholesterol, low-density lipoprotein cholesterol, HDL cholesterol, and triglyceride levels were measured in 1,609 consecutive patients admitted with an acute MI. The primary endpoint was all-cause mortality evaluated at 6 years with a median follow-up of 1.9 years (interquartile range: 1.5 to 4.2 years). An analysis by quartile of serum cholesterol efflux capacity was also performed. RESULTS: In a fully adjusted model that included age, sex, traditional cardiovascular risk factors including lipid levels, and prognostic factors of MI, serum cholesterol efflux capacity was a strong predictor of survival (adjusted hazard ratio for mortality per 1-SD increase in serum cholesterol efflux capacity, 0.79; 95% confidence interval: 0.66 to 0.95; p = 0.0132). Patients displaying an elevated serum cholesterol efflux capacity had a marked lower rate of mortality at 6 years (adjusted hazard ratio: 0.54 [0.32 to 0.89]; p = 0.0165) as compared with patients with reduced serum cholesterol efflux capacity. CONCLUSIONS: Serum cholesterol efflux capacity, an integrative marker of reverse cholesterol transport pathway and efficacy, was inversely associated with all-cause mortality in MI patients independently of HDL cholesterol level and other risk factors.
引用
- Guerin M, Silvain J, Gall J, et al. Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2018. PMID: 30573028. doi:10.1016/j.jacc.2018.09.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。